EA013052B1 - Лекарственное средство - Google Patents

Лекарственное средство Download PDF

Info

Publication number
EA013052B1
EA013052B1 EA200501366A EA200501366A EA013052B1 EA 013052 B1 EA013052 B1 EA 013052B1 EA 200501366 A EA200501366 A EA 200501366A EA 200501366 A EA200501366 A EA 200501366A EA 013052 B1 EA013052 B1 EA 013052B1
Authority
EA
Eurasian Patent Office
Prior art keywords
patients
group
treatment
substance
study
Prior art date
Application number
EA200501366A
Other languages
English (en)
Russian (ru)
Other versions
EA200501366A1 (ru
Inventor
Александр Леонидович Решетов
Ирина Анатольевна Верещагина
Original Assignee
Закрытое Акционерное Общество "Новая Линия"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое Акционерное Общество "Новая Линия" filed Critical Закрытое Акционерное Общество "Новая Линия"
Publication of EA200501366A1 publication Critical patent/EA200501366A1/ru
Publication of EA013052B1 publication Critical patent/EA013052B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200501366A 2004-03-26 2004-03-26 Лекарственное средство EA013052B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2004/000115 WO2005092344A1 (fr) 2004-03-26 2004-03-26 Preparation medicinale

Publications (2)

Publication Number Publication Date
EA200501366A1 EA200501366A1 (ru) 2006-08-25
EA013052B1 true EA013052B1 (ru) 2010-02-26

Family

ID=35055975

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501366A EA013052B1 (ru) 2004-03-26 2004-03-26 Лекарственное средство

Country Status (2)

Country Link
EA (1) EA013052B1 (fr)
WO (1) WO2005092344A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2136668C1 (ru) * 1997-10-07 1999-09-10 Голощапов Николай Михайлович N,n'-(сульфонилди-1,4-фенилен)бис(n'',n''- диметилформамидин)1,2,3,4-тетрагидро-6-метил-2,4- диоксо-5-пиримидинсульфонат, стимулирующий клеточный метаболизм и обладающий иммунотропной и антимикобактериальной активностью
RU2141322C1 (ru) * 1997-08-12 1999-11-20 Голощапов Николай Михайлович Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения
RU2191015C2 (ru) * 1999-11-05 2002-10-20 Общество с ограниченной ответственностью "Центр бифункциональных иммуномодуляторов" Динатриевая соль n-(6-метил-2,4-диоксо-1,2,3,4-тетрагидро-5h-пиримидинсульфон)-n'- изоникотиноилгидразида, проявляющая антимикробную и иммунотропную активность, и лекарственное средство на ее основе

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141322C1 (ru) * 1997-08-12 1999-11-20 Голощапов Николай Михайлович Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения
RU2136668C1 (ru) * 1997-10-07 1999-09-10 Голощапов Николай Михайлович N,n'-(сульфонилди-1,4-фенилен)бис(n'',n''- диметилформамидин)1,2,3,4-тетрагидро-6-метил-2,4- диоксо-5-пиримидинсульфонат, стимулирующий клеточный метаболизм и обладающий иммунотропной и антимикобактериальной активностью
RU2191015C2 (ru) * 1999-11-05 2002-10-20 Общество с ограниченной ответственностью "Центр бифункциональных иммуномодуляторов" Динатриевая соль n-(6-метил-2,4-диоксо-1,2,3,4-тетрагидро-5h-пиримидинсульфон)-n'- изоникотиноилгидразида, проявляющая антимикробную и иммунотропную активность, и лекарственное средство на ее основе

Also Published As

Publication number Publication date
WO2005092344A1 (fr) 2005-10-06
EA200501366A1 (ru) 2006-08-25

Similar Documents

Publication Publication Date Title
Weinberg Iron withholding: a defense against infection and neoplasia.
MANGI et al. Development of meningitis during cephalothin therapy
US20230121547A1 (en) A combination therapy with nirogacestat and a bcma-directed therapy and uses thereof
Brown et al. “Penbritin”—A New Broad-spectrum Antibiotic
CN1622814A (zh) 抗肿瘤活性吲哚并吡咯并咔唑衍生物和其它抗肿瘤药物的联合应用
WO2013058294A1 (fr) Agent thérapeutique pour le cancer du pancréas et/ou du cancer du tractus biliaire
JPS60256377A (ja) 食細胞セルラインの分析への利用
Reeves Sulphamethoxazole-trimethoprim: the first two years.
CN101370783B (zh) 9-氧代吖啶-10-乙酸和1-烷基氨基-1-脱氧多羟基化合物的盐和混合物、包含其的药物组合物以及治疗方法
FR2527441A1 (fr) Agent pour accroitre l'activite antitumorale d'un agent antitumoral et composition antitumorale le contenant
Booth et al. Immunosuppressive therapy in adults with proliferative glomerulonephritis: controlled trial
US20070225339A1 (en) Compositions and methods for treating rheumatoid arthritis
JP6089130B2 (ja) 抗生剤及びリゾホスファチジルコリンを含む免疫増強または細菌性感染疾患治療用の組成物
TW202228702A (zh) 一種吡啶并[1,2-a]嘧啶酮類似物的應用
Rubio et al. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients
Melink et al. Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-d-Ribofuranosylthiazole-4-carboxamide, NSC 286193)
US5158979A (en) Method and compositions for treating pneumocystic carini infections
EA013052B1 (ru) Лекарственное средство
WO1994028883A1 (fr) Compositions therapeutiques et procedes d'utilisation
EA002808B1 (ru) Бетаины, используемые в качестве адъювантов для проверки чувствительности и антимикробной терапии
KR102529024B1 (ko) 조혈, 면역-종양학 요법, 및 지질단백질 및 아포지질단백질 수준 조절에서의 베타-락탐의 치료 용도
Hallander et al. Pharmacological and Clinical Study of Bacampicillin in Acute Peritonsillitis–a Comparison with Ampicillin
CN112336864A (zh) 原黄素在肺癌治疗中的应用
JPS63264527A (ja) 抗エイズウイルス剤
UA23063U (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ